Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2007 Sep;44(16):3901-8.
doi: 10.1016/j.molimm.2007.06.145.

The role of complement system in ocular diseases including uveitis and macular degeneration

Purushottam Jha  1 , Puran S Bora, Nalini S Bora
Affiliations
Review

The role of complement system in ocular diseases including uveitis and macular degeneration

Purushottam Jha et al. Mol Immunol. 2007 Sep.

Abstract

In the normal eye, the complement system is continuously activated at low levels and both membrane-bound and soluble intraocular complement regulatory proteins tightly regulate this spontaneous complement activation. This allows protection against pathogens without causing any damage to self-tissue and vision loss. The complement system and complement regulatory proteins control the intraocular inflammation in autoimmune uveitis and play an important role in the development of corneal inflammation, age-related macular degeneration and diabetic retinopathy. The evidence derived from both animal models and patient studies support the concept that complement inhibition is a relevant therapeutic target in the treatment of various ocular diseases. Currently, several clinical trials using complement inhibitors are going on. It is possible that, in the near future, complement inhibitors might be used as therapeutic agents in eye clinics.

PubMed Disclaimer

Figures

Figure 1
Figure 1. Complement activation in the development of CNV
Laser photocoagulation results in up-regulation of factor B (↑) expression and decrease in (↓) factor H levels. This causes the activation and amplification of alternative pathway leading to increased deposition of MAC on the cell surface. After laser treatment the expression of CD59 is also down-regulated (↓) causing further loss of regulation (shown with X) and increased formation of MAC. Deposition of MAC results in release of growth factors such as VEGF, TGF-β2 and β-FGF, which leads to the formation of new blood vessels (shown within red circles). Administration of recombinant soluble CD59 (rs CD59) blocks (□) the formation of MAC and this results in inhibition of choroidal angiogenesis
See this image and copyright information in PMC

References

    1. Ahmed F, Brown KM, Stephan DA, Morrison JC, Johnson EC, Tomarev SI. Microarray analysis of changes in mRNA levels in the rat retina after experimental elevation of intraocular pressure. Invest. Ophthalmol. Vis. Sci. 2004;45:1247–1258. - PubMed
    1. Aiello LP. Angiogenic pathways in diabetic retinopathy. N. Engl. J. Med. 2005;353:839–841. - PubMed
    1. Anderson DH, Mullins RF, Hageman GS, Johnson LV. A role for local inflammation in the formation of drusen in the aging eye. Am. J. Ophthalmol. 2002;134:411–431. - PubMed
    1. Atkinson JP, Frank MM. Complement. In: Parker CW, editor. Clinical Immunology. WB Saunders; Philadelphia: 1980. pp. 219–271.
    1. Atkinson JP, Farries T. Separation of self from non-self in the complement system. Immunol. Today. 1987;8:212–215. - PubMed

Publication types

Substances